These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26510688)

  • 1. Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response.
    Samaranch L; Hadaczek P; Kells AP; Bringas JR; Stockinger D; San Sebastian W; Macayan M; Samineni S; Pivirotto P; Forsayeth J; Bankiewicz KS
    Gene Ther; 2016 Apr; 23(4):393-8. PubMed ID: 26510688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.
    Cunningham J; Pivirotto P; Bringas J; Suzuki B; Vijay S; Sanftner L; Kitamura M; Chan C; Bankiewicz KS
    Mol Ther; 2008 Jul; 16(7):1267-75. PubMed ID: 18523450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.
    Dodiya HB; Bjorklund T; Stansell J; Mandel RJ; Kirik D; Kordower JH
    Mol Ther; 2010 Mar; 18(3):579-87. PubMed ID: 19773746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.
    Li H; Murphy SL; Giles-Davis W; Edmonson S; Xiang Z; Li Y; Lasaro MO; High KA; Ertl HC
    Mol Ther; 2007 Apr; 15(4):792-800. PubMed ID: 17245353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain.
    Sullivan JA; Stanek LM; Lukason MJ; Bu J; Osmond SR; Barry EA; O'Riordan CR; Shihabuddin LS; Cheng SH; Scaria A
    Gene Ther; 2018 Jun; 25(3):205-219. PubMed ID: 29785047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.
    Martino AT; Basner-Tschakarjan E; Markusic DM; Finn JD; Hinderer C; Zhou S; Ostrov DA; Srivastava A; Ertl HC; Terhorst C; High KA; Mingozzi F; Herzog RW
    Blood; 2013 Mar; 121(12):2224-33. PubMed ID: 23325831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain.
    Hadaczek P; Kohutnicka M; Krauze MT; Bringas J; Pivirotto P; Cunningham J; Bankiewicz K
    Hum Gene Ther; 2006 Mar; 17(3):291-302. PubMed ID: 16544978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.
    Peden CS; Burger C; Muzyczka N; Mandel RJ
    J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
    Naumer M; Popa-Wagner R; Kleinschmidt JA
    J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.
    Hauck B; Xu RR; Xie J; Wu W; Ding Q; Sipler M; Wang H; Chen L; Wright JF; Xiao W
    Hum Gene Ther; 2006 Jan; 17(1):46-54. PubMed ID: 16409124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
    Mori S; Wang L; Takeuchi T; Kanda T
    Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cell recognition of epitopes within the capsid of adeno-associated virus 8-based gene transfer vectors depends on vectors' genome.
    Wu TL; Li H; Faust SM; Chi E; Zhou S; Wright F; High KA; Ertl HC
    Mol Ther; 2014 Jan; 22(1):42-51. PubMed ID: 24077034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical.
    He Y; Weinberg MS; Hirsch M; Johnson MC; Tisch R; Samulski RJ; Li C
    Hum Gene Ther; 2013 May; 24(5):545-53. PubMed ID: 23534873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming preexisting humoral immunity to AAV using capsid decoys.
    Mingozzi F; Anguela XM; Pavani G; Chen Y; Davidson RJ; Hui DJ; Yazicioglu M; Elkouby L; Hinderer CJ; Faella A; Howard C; Tai A; Podsakoff GM; Zhou S; Basner-Tschakarjan E; Wright JF; High KA
    Sci Transl Med; 2013 Jul; 5(194):194ra92. PubMed ID: 23863832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response.
    Hadaczek P; Forsayeth J; Mirek H; Munson K; Bringas J; Pivirotto P; McBride JL; Davidson BL; Bankiewicz KS
    Hum Gene Ther; 2009 Mar; 20(3):225-37. PubMed ID: 19292604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.
    Naidoo J; Stanek LM; Ohno K; Trewman S; Samaranch L; Hadaczek P; O'Riordan C; Sullivan J; San Sebastian W; Bringas JR; Snieckus C; Mahmoodi A; Mahmoodi A; Forsayeth J; Bankiewicz KS; Shihabuddin LS
    Mol Ther; 2018 Oct; 26(10):2418-2430. PubMed ID: 30057240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of CpG Sequences on Capsid-Specific CD8
    Xiang Z; Kurupati RK; Li Y; Kuranda K; Zhou X; Mingozzi F; High KA; Ertl HCJ
    Mol Ther; 2020 Mar; 28(3):771-783. PubMed ID: 31839483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice.
    Barker SE; Broderick CA; Robbie SJ; Duran Y; Natkunarajah M; Buch P; Balaggan KS; MacLaren RE; Bainbridge JW; Smith AJ; Ali RR
    J Gene Med; 2009 Jun; 11(6):486-97. PubMed ID: 19340848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.